2023-2024 COVID-19 Vaccine Efficacy Wanes Over Time
Drug Topics
JULY 21, 2025
A new study reveals the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Drug Topics
JULY 21, 2025
A new study reveals the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.
Drug Topics
JULY 8, 2025
Flip The Pharmacy November Schedule & Sign-Ups October 31st 2023 Article Check out these can't-miss Workflow Wednesdays sessions. CPESN Names Winners of 2023 Luminary of the Year Award October 25th 2023 Article This year's Luminary of the Year award winners were announced at the NCPA 2023 Annual Convention and Expo.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 30, 2025
From 2017 to 2023, the percentage of all opioid treatment programs offering 3 forms of medication for opioid use disorder (OUD) increased from 33% to 45%, but there is still a need to expand the offerings of OUD therapy across treatment programs. . 1 Data from 10,289 facility-year observations were used, with 1211 in 2017 and 1421 in 2023.
STAT
MARCH 18, 2025
However, between 2013 and 2023, private equity firms made over 1,000 acquisitions of disability and elder care providers — a likely undercount, according to the report published by the Private Equity Stakeholder Project, a nonprofit watchdog focused on the growing impact of the private equity industry.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
Explore the limitations of what we know about prescription drug dosing The future of Clinical Research April 12, 2023 at 11:00 am PDT, 2:00 pm EDT, 7:00 pm GMT Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development?
STAT
MARCH 18, 2025
When Ted Matthews came out of retirement in early 2023 to retake the helm of the rural Texas hospital where he’d started his health care career, it was something of a rescue mission. And yet, just 38 hospitals have taken up the new designation since 2023, fewer than researchers had predicted.
Drug Topics
AUGUST 12, 2025
Data for the prospective multisite survey study was gathered from 2 chain grocery stores in Maryland between December 2023 and March 2024. For the study, a survey was given to eligible patients who came to the pharmacy.
The Checkup by Singlecare
NOVEMBER 15, 2024
A 2011 study showed that the combination is more effective than amlodipine monotherapy, while one from 2023 demonstrated that it’s more effective than taking losartan alone.
Hospital Pharmacy Europe
MARCH 31, 2025
Circ Econ Sustainability 2025; March 3. 11 International Pharmaceutical Federation (FIP). Sustainability in healthcare: The role of the pharmacist and pharmacy practice – Report from an international roundtable. Accessed March 2025].
Pharmacy Times
AUGUST 13, 2025
Following the availability of RSV vaccines in 2023, researchers aimed to evaluate the uptake from August 2023 to February 2025 among adults aged 60 years and older, using IQVIA's open-source pharmacy (LRx) and medical (Dx) claims data. Patient follow-up ended at their first vaccination or at the conclusion of the study.
IDStewardship
JANUARY 13, 2025
2023 Jan 6;76(1):78-88. 2023 Jan 6;76(1):66-77. 2023 Sep 18;77(6):937. Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial. Clin Infect Dis. Dunne MW, et al. Clin Infect Dis. Erratum in: Clin Infect Dis. Orlynvah [package insert].
The Checkup by Singlecare
JUNE 5, 2025
Saudi Pharmaceutical Journal , 2023) Men are more likely to take statins compared to women. In fact, a 2023 study found that women were significantly less willing to take statins recommended by a healthcare provider. Saudi Pharmaceutical Journal, 2023) The cost of statins The U.S. In the U.S.,
STAT
OCTOBER 29, 2024
The first cycle of negotiations resulted in meaningful projected savings for Medicare and for people with Medicare — an estimated $6 billion for the program if the negotiated prices were in place in 2023 for the first 10 selected drugs, and $1.5
PharmaVoice
JULY 24, 2025
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from How Bristol Myers Squibb uses AI to validate (..)
Hospital Pharmacy Europe
JULY 1, 2025
In 2023, our pharmacy team identified digital overwhelm as a significant issue affecting staff morale and productivity. Top Tip 4: Prioritise digital wellbeing The rapid digitisation of healthcare has led to concerns about staff wellbeing.
Drug Topics
JULY 21, 2025
They were recruited from the International Pharmaceutical Federation (FIP) Congress in Brisbane, Australia, from September 24-28, 2023. Despite a small sample size and focus just on pharmacists at a 2023 event, the FIP aimed to use results from the study to inform the global understanding of pharmacists’ roles in health care.
Drug Topics
JULY 11, 2025
The retrospective cohort study gathered data from the Optum de-identified Clinformatics Data Mart Database from January 2015 through October 2023. A team of investigators from Avalere Health and Pfizer conducted a study to assess uptake of pneumococcal vaccine recommendations and disparities in uptake across subgroups of adult patients.
PharmaVoice
JUNE 23, 2025
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Megablockbusters are the holy grail.
PharmaVoice
JULY 21, 2025
3 major patent losses Johnson & Johnson’s Stelara, a blockbuster autoimmune therapy, peaked at nearly $11 billion in global sales in 2023 , but European and U.S. Here are three of the biggest drugs falling off the patent cliff this year and what companies can do to soften the blow. biosimilars took a $1.2
Drug Topics
AUGUST 8, 2025
Updated December 18, 2023. AI’s role in revolutionizing personalized medicine by reshaping pharmacogenomics and drug therapy. 2024;2(5):643-650. doi:10.1016/j.ipha.2024.08.005 2024.08.005 18. Cell therapy basics. American Society of Gene and Cell Therapy. Accessed June 2, 2025. Capsa Healthcare. Accessed June 4, 2025.
PharmaVoice
JULY 1, 2025
The company’s pipeline includes other candidates aimed at IBS indications. “I I wanted to create a shared definition of patient centricity here at Ardelyx, and then weave that into the fabric of the organization."
Pharma Times
AUGUST 5, 2025
Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023
PQA
JUNE 6, 2025
Studying the Impact of Insulin Cost Cap In 2023, insulin costs were capped at $35 for Medicare enrollees under the Inflation Reduction Act. By providing personalized resources, maintaining patient communication, and collaborating with health plans, pharmacists can play a crucial role in improving overall patient outcomes.
Hospital Pharmacy Europe
AUGUST 13, 2025
Between July 2022 and January 2023, a survey was distributed to chief and senior pharmacists across all UK mental health organisations to identify existing prioritisation tools and systems. This study aimed to explore the tools used by UK inpatient mental health pharmacy teams to achieve this.
The Checkup by Singlecare
JUNE 5, 2025
Diabetologia , 2023) In 2018, an estimated 5,300 American youth were diagnosed with Type 2 diabetes. (National Diabetes Statistics Report, 2024) Type 2 diabetes incidence increases with age. ADA, 2025) Men are slightly more likely than women to be diagnosed with Type 2 diabetes.
Drug Topics
JUNE 11, 2025
1 Natural disasters have reached unprecedented levels in the past 5 years, with 2020, 2023, and 2024 being the most destructive and costly since before 1980. One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires.
Pharmacy Times
JUNE 24, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
Pharma Times
JULY 23, 2025
Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023
Drug Topics
JULY 10, 2025
Daymon, 2022 Private Brand Intelligence Report, May 2023. McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare. McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.
PharmaVoice
JUNE 6, 2025
For example, Pfizer, which acquired early ADC innovator Seagen in 2023, is going after a familiar target in the oncology arena: the PD-(L)1 pathway. HER2 has been around for a long time and remains an established target, but now we’re seeing much bigger development in the payloads themselves for a next generation of ADCs.”
Pharmacy Times
AUGUST 6, 2025
According to the CDC, national kindergarten vaccination coverage dropped to 93% in the 2023-2024 school year, down from prepandemic levels of approximately 95%. Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates.
Pharma Times
AUGUST 6, 2025
Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023
Pharmacy Times
AUGUST 12, 2025
1,6,7 Robust Immunogenicity Elicited From V116 Compared With PPSV23 Between January 2023 and May 2023, individuals who were vaccine-naïve were recruited across 8 health care centers in Japan. Enrollees were randomized 1:1 to receive a single dose of V116 or PPSV23.
PharmaVoice
JULY 31, 2025
Kenvue’s shaky future Johnson & Johnson’s decision to spin off its consumer health business in 2023 followed a wave of similar moves by major pharma companies such as Sanofi and GSK. The goal was to streamline, simplify and refocus on the business of innovating drugs.
Drug Topics
JULY 2, 2025
1 Exploring recent evidence of GLP-1RA efficacy and safety, researchers conducted a literature search spanning from June 2023 to January 2025. July 3, 2023. All included studies featured adults over 18 with T1D, a body mass index (BMI) of 25 kg/m 2 or greater, and a GLP-1RA treatment regimen including insulin for at least 12 weeks.
The FDA Law Blog
JULY 8, 2025
2023); FDA, Guidance, Control of Nitrosamine Impurities in Human Drugs at 12 (Sept. Coupled with the aforementioned August 2023 NDSRI guidance on acceptable intake limits, testing, and mitigation frameworks and the September 2024 guidance on the control of NDSRIs, this update offers a pragmatic pathway forward for manufacturers.
Drug Topics
AUGUST 7, 2025
2 The current study, which was a 26-week, randomized, double-blind trial, was conducted at 5 sites in Mexico between February 2022 and February 2023 and included patients aged 18 to 75 years with a type 2 diabetes diagnosis for 6 or more months. Further, there are also benefits in cardiovascular effects and weight management.
European Pharmaceutical Review
JUNE 19, 2025
Interinstitutional File: 2023/0131 (COD). Proposal For a Regulation Of The European Parliament And Of The Council Laying Down Union Procedures For The Authorisation And Supervision Of Medicinal Products For Human Use And Establishing Rules Governing The European Medicines Agency – Mandate For Negotiations With The European Parliament.
The Happy PharmD
MARCH 30, 2025
Yet, a 2023 survey found that 54% of Americans mistakenly believe all online pharmacies are FDA-approved. They lure in desperate patients looking for affordability, only to sell them fake or unsafe medications. Some contain the wrong active ingredient. Some have no active ingredient at all. Some are straight-up toxic.
Pharmacy Times
JULY 22, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
Pharmacy Times
JULY 22, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
Pharmacy Times
JULY 16, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
Hospital Pharmacy Europe
MARCH 18, 2025
The European Association of Hospital Pharmacists (EAHP) 2023 Shortage Survey Report revealed that 59% of pharmacists found drug supply chain issues contributed to delays in patient care, 43% confirmed that drug supply chain issues led to suboptimal treatment, and 35% noted care cancellations as a result.
Pharmacy Times
AUGUST 5, 2025
During the 2023-2024 influenza season, only 44.9% link] Flu vaccination coverage, United States, 2023-24 influenza season. January 10, 2023. The following are suggestions for pharmacists looking to utilize community connections to fight influenza. Accessed June 10, 2025. September 20, 2024. Accessed June 10, 2025.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content